Dialysis Device and Concentrates Market Growing at 6 % CAGR, Expected to Reach USD 34.47 billion by 2033 - Strategic Revenue Insights

London, UK - Dec 2, 2025 | Strategic Revenue Insights Inc. - The global Dialysis Device and Concentrates market is on track for strong expansion, with new projections showing the sector growing from a base of US$20.40 billion in 2023 to reach approximately US$34.47 billion by 2033.

This trajectory reflects a compound annual growth rate (CAGR) of 6 %, underlining a steady uptick in demand for dialysis devices, concentrates, and related consumables worldwide.

The climb from US$21.66 billion in 2023 to US$34.82 billion by 2033 demonstrates a remarkable rise in overall market value an increase of roughly 61 percent over the decade. This growth highlights expanding adoption of dialysis treatment globally and a rising need for high-quality dialysis consumables and devices (dialyzers, concentrates, water-treatment components, and associated equipment) to support both clinical and home-based dialysis settings.

A comprehensive assessment of this rapidly evolving market can be accessed through Strategic Revenue Insights at the link below, focused on Dialysis Device and Concentrates:

https://www.strategicrevenueinsights.com/industry/dialysis-device-and-concentrates-market

Underlying this expansion is a sharp increase in the prevalence of chronic kidney disease (CKD) and associated comorbidities such as diabetes and hypertension conditions that often lead to end-stage renal disease (ESRD) and necessitate long-term dialysis therapy. As populations age in many countries and awareness of renal healthcare improves, more patients are entering dialysis programs. This in turn fuels demand for devices and concentrates, which remain the backbone of hemodialysis and peritoneal dialysis therapies.

The shift toward home-based dialysis, rising healthcare expenditure in developing nations, and improved access to renal care also amplify market growth.

Regionally, demand gains are visible across all major geographies. Developed regions such as North America and Europe continue to account for a sizeable share, driven by established dialysis infrastructure, favorable reimbursement policies, and regulatory frameworks supporting renal therapies.

Meanwhile, emerging economies in Asia Pacific and Latin America are registering faster growth thanks to rising burden of kidney diseases, expanding healthcare infrastructure, and rising awareness of dialysis treatment leading to increasing penetration of dialysis devices and concentrates in those markets. Notably, in regions such as Asia-Pacific, rising incidence of chronic kidney disorders and growing investments in healthcare are pushing consumption of dialysis devices and consumables upward.

Browse the associated report:

https://www.strategicrevenueinsights.com/ja/industry/dialysis-device-and-concentrates-market

https://www.strategicrevenueinsights.com/kr/industry/dialysis-device-and-concentrates-market

https://www.strategicrevenueinsights.com/da/industry/dialysis-device-and-concentrates-market

https://www.strategicrevenueinsights.com/de/industry/dialysis-device-and-concentrates-market

The competitive landscape shows a mix of global and regional players offering a wide range of products from dialysis machines and water-treatment systems to concentrates, dialyzers, filters, and accessories. Leading companies such as Fresenius Medical Care and Baxter International, Inc. dominate a significant share of the device and concentrates market, offering comprehensive product portfolios for hemodialysis and peritoneal dialysis. Other important names operating in this space include B. Braun Melsungen AG, Nipro Corporation, Nikkiso Co., Ltd., Toray Medical Co. Ltd. and Asahi Kasei Corporation. These companies continue to invest in product innovation, regional expansion and capacity enhancements to meet the growing global demand for dialysis solutions.

From a segmentation perspective, the Dialysis Device and Concentrates market divides broadly by product type and end user. Product-wise, the market spans dialysis machines, dialyzers, concentrates (liquid and powder-based), water-treatment systems, and other consumables necessary for dialysis therapy. End-user segmentation shows that hospital-based dialysis centers remain the largest consumers, but home-based dialysis and independent dialysis clinics (especially in emerging economies) are gradually gaining share.

The shift toward home-use modalities is particularly significant in regions where healthcare systems are evolving to adopt patient-centric care models. Moreover, the rising demand for peritoneal dialysis systems and portable devices driven by patient preference for convenience and cost-efficiency contributes to a diversified product mix.

Looking ahead to 2033 and beyond, the Dialysis Device and Concentrates market appears ripe with opportunity. As chronic kidney disease incidence continues to rise globally (spurred by aging populations and lifestyle-related illnesses), demand for dialysis solutions will only intensify. Investment in R&D particularly around more compact, efficient, and patient-friendly dialysis devices, as well as advanced concentrates and water-purification systems is likely to create differentiation in a competitive market.

Manufacturers that expand into emerging markets, enhance supply chain resilience, and obtain regulatory approvals will likely capture outsized growth. Rising interest in home dialysis options, improved insurance coverage, and growing government support for renal healthcare present further opportunities for market expansion and increased device adoption.

Related Reports:

https://www.strategicrevenueinsights.com/industry/menopause-wellness-market

Media Contact

Company Name: Strategic Revenue Insights Inc.

Contact Person: Ashwani

Email: sales@strategicrevenueinsights.com

Phone: +44 7877 403352

Address: Suite 10, Capital House, 61 Amhurst Road, E8 1LL

City: London

Country: United Kingdom

Website: www.strategicrevenueinsights.com

Website: www.strategicpackaginginsights.com

About Strategic Revenue Insights Inc.
Strategic Revenue Insights Inc., a subsidiary of SRI Consulting Group Ltd, empowers organizations worldwide with data driven market intelligence. Headquartered in London, United Kingdom, the firm delivers syndicated research reports, tailored consulting solutions, and actionable insights that equip clients to make confident, future focused strategic decisions. Its team of seasoned analysts continuously tracks markets, identifies emerging trends, and uncovers growth opportunities to support long-term client success. As part of SRI Consulting Group Ltd, Strategic Revenue Insights Inc. is committed to accuracy, clarity, and practical relevance, helping businesses optimize strategies and accelerate revenue growth.

This release was published on openPR.